Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,302 | 9,742 | 13,362 | 15,964 | 12,698 |
| Marketable Securities | N/A | N/A | N/A | N/A | 6,994 |
| TOTAL | $7,489 | $10,293 | $13,995 | $16,844 | $19,873 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1 | 1 | 1 |
| Other Non-Current Assets | 633 | 656 | 928 | 949 | 971 |
| TOTAL | $633 | $656 | $929 | $951 | $972 |
| Total Assets | $8,122 | $10,949 | $14,924 | $17,794 | $20,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,825 | 1,435 | 2,672 | 2,264 | 2,003 |
| TOTAL | $1,928 | $1,537 | $2,774 | $2,365 | $2,103 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 28 | 51 | 73 | 95 | 116 |
| TOTAL | $28 | $51 | $73 | $95 | $116 |
| Total Liabilities | $1,956 | $1,588 | $2,847 | $2,460 | $2,219 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 364 | 305 | 305 | 300 | 300 |
| Common Shares | 86 | 85 | 84 | 84 | 84 |
| Retained earnings | -53,239 | -49,224 | -45,417 | -41,414 | -37,492 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 134 |
| TOTAL | $6,166 | $9,361 | $12,077 | $15,334 | $18,626 |
| Total Liabilities And Equity | $8,122 | $10,949 | $14,924 | $17,794 | $20,845 |